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Background 
The term “probiotic” was popularized more than twenty years ago (1), and more 
recently defined as “living microorganisms which, when administered in adequate 
amounts, confer a health effect on the host” (2). Traditionally, probiotics are shown to 
be beneficial in numerous inflammatory and allergic, mostly gastrointestinal, 
diseases (3). However, orally consumed probiotics were also found to improve 
conditions of other organs, skin included (s1, s2, 4). 
Importantly, recent intriguing data suggest that microorganism-based topical 
formulations are also highly effective in various skin conditions. Indeed, locally 
applied living Lactobacillus plantarum suppressed inflammation and accelerated 
wound healing in patients with chronic infected leg ulcers (5). Topical formulation 
containing nonpathogenic Gram-negative bacterium Vitreoscilla filiformis lysates 
improved symptoms and promoted the repair of the skin barrier in atopic dermatitis 
patients (6). Of further importance, a specific Bifidobacterium longum (B. longum) 
extract from CLR Richter laboratories (Berlin, Germany), when applied as a cream to 
volunteers with reactive skin, significantly decreased cutaneous sensitivity, increased 
skin resistance, and decreased skin dryness, and strengthened the cutaneous 
barrier (7). In addition, this B. longum extract inhibited neuropeptide-induced 
inflammatory cutaneous response in organ-cultured human skin, and inhibited the 
release of neuropeptides from capsaicin-stimulated cultured sensory neurons (7). 
 
Questions Addressed 
Epidermal keratinocytes are key players in establishing and maintaining the complex 
cutaneous barrier homeostasis (s3). However, very limited information is available 
on the direct actions of beneficial microorganisms on these cells. Therefore, in the 
current study, as a continuation of previously published work (7), the effects of 
various preparations of B. longum, one of the most widely used probiotics, were 
investigated on cellular functions of primary normal human epidermal keratinocytes 
(NHEKs).  
 
Experimental Design 
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In this study the following B. longum preparations (BL) were used to examine their 
effect on the viability, differentiation, antimicrobial peptide production and calcium 
homeostasis:  
- N° 64, the non-replicative bacteria (heat-treated) from Nestle research center; 
B. longum NCC3001 (BL/64) 
- N° 81,  the non-replicative bacteria (heat-treated) from Nestle research center; 
B. longum NCC2705 (BL/81) 
- N° 84, the B. longum reuter extract by sonication from Richter (INCI Bifida 
ferment lysate, 7; BL/84)  
 
Results 
First, the effect of the various BL preparations on the growth of the keratinocytes was 
assessed. Treatment of pre-confluent (i.e. proliferating) NHEKs with various 
concentrations of BL for up to 72 hrs did not modify the proliferation (as assessed by 
MTT assay) of the cells (Supplementary Figure S1 online). In addition, as MTT assay 
determines the viable cell number, it can also be concluded that none of the BL 
extract affected the viability of the NHEKs. Therefore, throughout the experiments, 
the highest BL extract concentrations were employed (3 v/v %). 
 
Next, the effects of BL preparations on the epidermal differentiation process was 
investigated. For this, the expression of various differentiation markers (s3) was 
compared in proliferating (pre-confluent) and differentiating NHEKs; the latter was 
achieved by culturing the cells for 2 days after reaching confluence (high cell density-
induced differentiation model; s4). As expected (Figure 1A), the expression of 
differentiation markers (KRT1, TGM1) was significantly higher in the post-confluent 
cultures (when compared to the pre-confluent ones).  
 
Importantly, treatment of pre-confluent NHEK with BL/81 increased the expression of 
all differentiation markers (Figure 1B-E) to much higher levels than seen in the 
control (untreated) post-confluent cells (Figure 1A, C-E). 
 
BL/84 also up-regulated the levels of keratin (KRT) 1, KRT10, and transglutaminase 
1 (TGM1). However, it did not induce an increase in filaggrin, loricrin, and involucrin. 
Interestingly, BL/64 was ineffective in these assays. 
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The effects of BL on the expression of certain antimicrobial peptides (AMP) (β 
defensin 1 –BDEF- and Cathepsin S) and molecules with pivotal role in wound 
healing (Cathepsins B, D and H) (s5; s6; 8) was also examined. Interestingly, levels 
of most of these markers (the only exception was Cathepsin S) were significantly 
elevated in post-confluent differentiating NHEKs (Figure 2A, C, D).  
 
Therefore, in the subsequent experiments, only pre-confluent NHEKs were treated 
by BL. As shown in Figure 2, BL/81 and BL/84 (with BL/81 being more efficient) 
markedly elevated the levels of mRNA transcripts and released amount of all (BL/81) 
or most (BL/84) molecules, BL/64, again, proved to be almost ineffective significantly 
up-regulating BDEF-specific mRNAs albeit not causing the release of the AMP. 
 
Although the exact signaling pathway(s) that mediate the above effects remain to be 
determined, we have preliminarily attempted to assess the effect of BL extracts on 
the intracellular calcium levels, the elevation of which is one of the key factors that 
induce differentiation in NHEKs (s7). Importantly, only BL/81 (but not BL/84 or BL/ 
64) was effective in elevating the calcium concentration of the cells. This effect was 
completely absent when calcium was removed from the medium suggesting that 
BL/81 induces a calcium influx from the extracellular medium (Figure 2E-F). 
 
Conclusions 
The intriguing findings of this study provide the first evidence that certain B. longum 
extract preparations exhibit significant pro-differentiating and potentially pro-
regenerating (cathepsins’ expression) actions in NHEKs, together with an increased  
expression of BDEF, one key actor of cutaneous innate immune response. In the 
single available previous study, various probiotics (certain B. longum and 
Lactobacillus strains) were shown to increase the expression of multiple tight-
junction proteins of NHEKs and enhanced barrier function (a decreased 
transepidermal water loss) (9). These data, therefore, collectively suggest that the 
beneficial effects of topical microbial formulations derived from bacteria may be 
mediated, at least in part, by direct modulation of epidermal keratinocytes’ 
differentiation, most probably via inducing Ca2+ influx. 
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Figure legends 
Figure 1. Effects of probiotics on differentiation of NHEKs 
(A) QPCR evaluation of differentiation markers (cytokeratin KRT1, KRT10, and 
transglutaminase TGM1) in pre-confluent (proliferating) and post-confluent 
(differentiating) NHEKs. Data are calculated using the ∆∆CT method using β-actin as 
an internal housekeeping gene. Results are expressed as mean±SD of three 
independent determinations relative to the pre-confluent cultures (defined as 1). 
*P<0.05 compared to expression determined in the pre-confluent cultures. (B) 
Similar QPCR evaluation of the above differentiation markers after treatment of pre-
confluent NHEKs with various BLs (3%, 48 hrs). *P<0.05 compared to expression 
determined in the vehicle-treated cultures (defined as 1, solid line). (C-E) Western 
blot analysis of filaggrin (FIL), involucrin (INV) and loricrin (LOR) in the pre- and post-
confluent NHEKs as well as after the above probiotics treatment. Relative optical 
density (OD) values were determined by normalizing the intensity of each band to 
the OD of their respective β-actin control; expression in the pre-confluent vehicle-
treated cultures was defined as 1. Two-three additional experiments yielded similar 
results. 
 
Figure 2. Effect of probiotics on the expression of antimicrobial peptides and wound 
healing markers and on the intracellular calcium levels of NHEKs 
(A) QPCR evaluation of antimicrobial peptides (β defensin 1 [BDEF], Cathepsin S) 
and molecules pivotal in wound healing (Cathepsins B, D and H) in pre-confluent 
(proliferating) and post-confluent (differentiating) NHEKs. Data are calculated using 
the ∆∆CT method using β-actin as an internal housekeeping gene. Results are 
expressed as mean±SD of three independent determinations relative to the pre-
confluent cultures (defined as 1). *P<0.05 compared to expression determined in the 
pre-confluent cultures. (B) Similar QPCR evaluation of the above markers after 
treatment of pre-confluent NHEKs with various BL extracts (3%, 48 hrs). *P<0.05 
compared to expression determined in the vehicle-treated cultures (defined as 1). 
(C,D) ELISA analysis of the released BDEF and Cathepsin B in the pre- and post-
confluent NHEKs as well as after the above probiotics treatment. *P<0.05 compared 
to levels determined in the pre-confluent cultures. (E) Fluorimetric Ca2+ imaging 
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using Fluo-4. BL/81 (3%) was applied as indicated by the arrow; as a positive 
control, ATP (180 µM) was administered. Experiments were performed in media with 
high (1.8 mM) and low (0.1 mM) Ca2+ concentration. (F) Statistical analysis of Ca2+-
signals measured in the two media in four independent determinations. Results are 
expressed as mean±SD. *P<0.05 
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Supplementary Figure 1
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SUPPLEMENTARY INFORMATION 
 
Supplementary Materials and Methods 
Cell culturing 
Human skin samples were obtained after written informed consent from healthy 
individuals undergoing surgery, adhering to Helsinki guidelines, and after obtaining 
Institutional Research Ethics Committee's permission (protocol No.: DE OEC 
RKEB/IKEB 3724-2012; document No.: IX-R-052/01396-2/2012). NHEKs were 
isolated after overnight dermal–epidermal separation in 2.4 U ml−1 dispase (Roche 
Diagnostics, Berlin, Germany) by short trypsin (0.05%, Sigma-Aldrich, St. Louis, MO) 
digestion. Cells were cultured in EpiLife serum-free media supplemented with 
Human Keratinocyte Growth Supplement (both from Life Technologies, Carlsbad, 
CA). 
 
Assessment of viability 
Cells were plated in 96-well plates (20,000 cells per well density, which 
corresponded to approximately 70–80% confluence) in quadruplicate, treated for two 
days with the given concentration of probiotics. The number of viable cells was 
determined by measuring the conversion of the tetrazolium salt MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; Sigma-Aldrich) to formazan by 
mitochondrial dehydrogenases. In all cases, experiments were repeated at least 
three times. 
 
Quantitative RT PCR 
Q-PCR was performed on an ABI Prism 7000 sequence detection system (Applied 
Biosystems, Foster City, CA) by using the 5′ nuclease assay. Total RNA was isolated 
using TRIzol (Invitrogen, Carlsbad, CA). One µg of total RNA were then reverse-
transcribed into cDNA by using the High Capacity cDNA Reverse Transcription Kit 
(Applied Biosystems) according to the manufacturer’s protocol. PCR amplification 
was performed by using the TaqMan primers and probes (assay IDs: 
Hs00608345_m1 for human BDEF; Hs00947433_m1 for Cathepsin B, 
Hs00157201_m1 for Cathepsin D, Hs00544778_m1 for Cathepsin H, for 
Hs00175403_m1 Cathepsin S, Hs00196158_m1 for KRT1, Hs00818825_m1 for 
KRT7, Hs00413861_m1 for KRT9, Hs00166289_m1 for KRT10, Hs00165921_m1 
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for TGM1) using the TaqMan universal PCR master mix protocol (Applied 
Biosystems). As internal controls, transcripts of β-actin were determined (assay ID, 
Hs99999903_m1). 
 
Western blotting 
Keratinocytes were harvested and lysed in ice-cold lysis buffer (20 mm Tris-HCl (pH 
7.5), 5 mm EGTA, protease inhibitor cocktail 1:100, all from Sigma-Aldrich). After 
determining the protein content, 100 µg protein from each sample was subjected to 
SDS-PAGE, transferred to BioBond nitrocellulose membranes (Whatman, 
Maidstone, UK), and then probed with antibodies against filaggrin, loricrin and 
involucrin (all used in a ratio of 1:250, all from Sigma-Aldrich). A horseradish 
peroxidase-conjugated goat anti-rabbit IgG antibody (1:1,000, Bio-Rad, Hercules, 
CA) was used as a secondary antibody, and the immunoreactive bands were 
visualized by a SuperSignal West Pico Chemiluminescent Substrate-Enhanced 
Chemiluminescence kit (Pierce, Rockford, IL) using LAS-3000 Intelligent Dark Box 
(Fuji, Tokyo, Japan). To assess equal loading, membranes were re-probed with an 
anti-β-actin antibody (1:1000, Sigma-Aldrich) and visualized as described above. 
Semiquantitative densitometric analysis of the signals was performed by using 
Image J software (National Institutes of Health,Bethesda, MD, USA). 
 
ELISA 
Secreted levels of β-defensin (Uscn Life Science Inc, Houston, TX) and Cathepsin B 
(Biorbyt LLC, San Francisco, CA) were determined from supernatants of probiotic 
treated NHEKs using pre-coated ELISA plates according to the manufacturer’s 
protocol. Briefly, the supernatants were centrifuged for 10 minutes at 300 gs to 
remove bacterial debris, and subsequently diluted 100-fold. 
 
Calcium measurement 
Changes in intracellular Ca2+ concentration upon probiotic application were detected 
by fluorimetric Ca2+ imaging. Cells were seeded in 96-well black-well/clear-bottom 
plates (Greiner Bio One, Frickenhausen, Germany) at a density of 10,000 cells per 
well and then were incubated with culturing medium containing the cytoplasmic 
calcium indicator 2 µM Fluo-4 AM (Life Technologies, Waltham, MA) at 37 °C for 
40 minutes. The cells were washed four times with and finally cultured in Hank's 
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balanced salt solution containing 1% bovine serum albumin and 2.5 mM probenecid 
(both from Sigma-Aldrich) for 30 minutes at 37 °C. The plates were then placed to a 
FlexStation 3 FLIPR (Molecular Devices, San Francisco, CA) and changes in 
intracellular Ca2+ concentration (reflected by changes in fluorescence; lEX=494 nm, 
lEM=516 nm) induced by various concentrations of the drugs were recorded in each 
well (during the measurement, cells in a given well were exposed to only one given 
concentration of the agent). 
 
Statistical evaluation 
When applicable, data were analyzed using a two-tailed un-paired t-test and P < 
0.05 values were regarded as significant differences. 
 
 
Supplementary Figure legends 
Supplementary Figure 1. Effects of bacterial extract on proliferation and viability of 
NHEKs 
Proliferation and viability of pre-confluent NHEKs were assessed by MTT assay after 
48 hrs treatment with various concentrations of BLs. Results are expressed as 
mean±SD of four independent determinations (untreated control was defined as 1). 
Two additional experiments yielded similar results. 
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Supplementary Discussion 
 
The upregulation of AMPs and Cathepsins in addition to their putative effects on 
wound healing, may also influence the local inflammatory milieu. Human beta 
defensin-1 for example has been shown (S8) to be anti-inflammatory in 
macrophages, where their upregulation resulted in decreased inflammatory cytokine 
expression (TNF-α, IL-6 and CXCL2). Cathepsin B has been shown to be 
instrumental for the development of the inflammatory response to mercury-induced 
autoimmunity (S9), and is also important in the immune response in inflammatory 
myopathies alongside Cathepsin H (S10). Cathepsin S has been shown to be 
instrumental in the innate immune response by regulating IL-1β, since extracellular 
Cathepsin S is required for the maturation of the cytokine (S11). It is also highly 
expressed in macrophages (S12), takes part in MHC class II antigen presentation 
(S13) and toll-like receptor signalling (S14). Whether the combination of these 
factors results in pro- or anti-inflammatory effects requires further investigation. 
  
Page 13 of 16
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
Supplementary References 
S1 Peguet-Navarro J, Dezutter-Dambuyant C, Buetler T, Leclaire J, Smola H, Blum S, et al. Supplementation with 
oral probiotic bacteria protects human cutaneous immune homeostasis after UV exposure-double blind, 
randomized, placebo controlled clinical trial. Eur J Dermatol. 2008;18(5):504-11. 
 
S2 Kano M, Masuoka N, Kaga C, Sugimoto S, Iizuka R, Manabe K, et al. Consecutive Intake of Fermented Milk 
Containing Bifidobacterium breve Strain Yakult and Galacto-oligosaccharides Benefits Skin Condition in Healthy 
Adult Women. Biosci Microbiota Food Health. 2013;32(1):33-9. 
 
S3 Elias PM, Feingold KR. Skin barrier. New York: Taylor & Francis; 2006. xviii, 612 p. p. 
 
S4 Papp H, Czifra G, Lazar J, Gonczi M, Csernoch L, Kovacs L, et al. Protein kinase C isozymes regulate proliferation 
and high cell density-mediated differentiation in HaCaT keratinocytes. Exp Dermatol. 2003;12(6):811-24. 
 
S5 Zeeuwen PLJM. Epidermal differentiation: The role of proteases and their inhibitors. Eur J Cell Biol. 
2004;83(11):761-73. 
 
S6 Gallo RL, Hooper LV. Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol. 
2012;12(7):503-16. 
 
S7 Hennings H, Michael D, Cheng C, Steinert P, Holbrook K, Yuspa SH. Calcium regulation of growth and 
differentiation of mouse epidermal cells in culture. Cell. 1980;19(1):245-54. 
 
S8 Ann S-J, Chung J H, Park B H et al. PPARα agonists inhibit inflammatory activation of macrophages through 
upregulation of β-defensin 1. Atherosclerosis 2015: 240: 389–397. 
 
S9 Toomey C B, Cauvi D M, Hamel J C et al. Cathepsin B regulates the appearance and severity of mercury-
induced inflammation and autoimmunity. Toxicol Sci 2014: 142: 339–349. 
 
S10 Kumamoto T, Ueyama H, Sugihara R et al. Calpain and cathepsins in the skeletal muscle of inflammatory 
myopathies. Eur Neurol 1997: 37: 176–181. 
 
S11 Hughes C S, Colhoun L M, Bains B K et al. Extracellular cathepsin S and intracellular caspase 1 activation are 
surrogate biomarkers of particulate-induced lysosomal disruption in macrophages [Internet]. Part Fibre Toxicol 
2016: 13[cited 2016 May 30]  DOI: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842290/ 
 
S12 Shi G P, Webb A C, Foster K E et al. Human cathepsin S: chromosomal localization, gene structure, and tissue 
distribution. J Biol Chem 1994: 269: 11530–11536. 
 
S13 Riese R J, Wolf P R, Brömme D et al. Essential role for cathepsin S in MHC class II-associated invariant chain 
processing and peptide loading. Immunity 1996: 4: 357–366. 
 
S14 Park B, Brinkmann M M, Spooner E et al. Proteolytic cleavage in an endolysosomal compartment is required 
for activation of Toll-like receptor 9. Nat Immunol 2008: 9: 1407–1414. 
 
 
Page 14 of 16
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
  
 
 
Figure 1. Effects of probiotics on differentiation of NHEKs  
(A) QPCR evaluation of differentiation markers (cytokeratin KRT1, KRT10, and transglutaminase TGM1) in 
pre-confluent (proliferating) and post-confluent (differentiating) NHEKs. Data is calculated using the ∆∆CT 
method using β-actin as an internal housekeeping gene. Results are expressed as mean±SD of three 
independent determinations relative to the pre-confluent cultures (defined as 1). *P<0.05 compared to 
expression determined in the pre-confluent cultures. (B) Similar QPCR evaluation of the above differentiation 
markers after treatment of pre-confluent NHEKs with various BLs (3%, 48 hrs). *P<0.05 compared to 
expression determined in the vehicle-treated cultures (defined as 1, solid line). (C-E) Western blot analysis 
of filaggrin (FIL), involucrin (INV) and loricrin (LOR) in the pre- and post-confluent NHEKs as well as after 
the above probiotics treatment. Relative optical density (OD) values were determined by normalizing the 
intensity of each band to the OD of their respective β-actin control; expression in the pre-confluent vehicle-
treated cultures was defined as 1. Two-three additional experiments yielded similar results.  
 
185x155mm (300 x 300 DPI)  
 
 
Page 15 of 16
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
  
 
 
Figure 2. Effect of probiotics on the expression of antimicrobial peptides and wound healing markers and on 
the intracellular calcium levels of NHEKs  
(A) QPCR evaluation of antimicrobial peptides (β defensin 1 [BDEF], Cathepsin S) and molecules pivotal in 
wound healing (Cathepsins B, D and H) in pre-confluent (proliferating) and post-confluent (differentiating) 
NHEKs. Data is calculated using the ∆∆CT method using β-actin as an internal housekeeping gene. Results 
are expressed as mean±SD of three independent determinations relative to the pre-confluent cultures 
(defined as 1). *P<0.05 compared to expression determined in the pre-confluent cultures. (B) Similar QPCR 
evaluation of the above markers after treatment of pre-confluent NHEKs with various BL extracts (3%, 48 
hrs). *P<0.05 compared to expression determined in the vehicle-treated cultures (defined as 1). (C,D) 
ELISA analysis of the released BDEF and Cathepsin B in the pre- and post-confluent NHEKs as well as after 
the above probiotics treatment. *P<0.05 compared to levels determined in the pre-confluent cultures. (E) 
Fluorimetric Ca2+ imaging using Fluo-4. BL/81 (3%) was applied as indicated by the arrow; as a positive 
control, ATP (180 µM) was administered. Experiments were performed in media with high (1.8 mM) and low 
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(0.1 mM) Ca2+ concentration. (F) Statistical analysis of Ca2+-signals measured in the two media in four 
independent determinations. Results are expressed as mean±SD. *P<0.05  
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